| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 7 505-512, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
JF Bromberg, Z Fan, C Brown, J Mendelsohn and JE Darnell Jr
Laboratory of Cell Biology, The Rockefeller University, New York, New York 10021-6399, USA.
Epidermal growth factor (EGF) is a mitogen for most epithelial cells. Paradoxically, the growth of some cultured cell lines, containing high numbers of EGF receptors, are inhibited by EGF. Here we demonstrate that growth inhibition by EGF in several cell lines correlates with the activation of the signal transducer and activator of transcription (Stat) 1. In contrast, in normal fibroblasts and several cell lines that are growth stimulated by EGF, we observed no or very transient activation of Stat1. A causal association between Stat1 activation by EGF and growth inhibition was suggested by the expression of a dominant-negative Stat1 in A431 cells, resulting in the loss of Stat1 DNA binding and concomitant resistance to growth inhibition by EGF. We conclude that, in the cells examined, EGF-induced arrest of growth requires activated Stat1.
This article has been cited by other articles:
![]() |
F. Graziano, A. Ruzzo, F. Loupakis, E. Canestrari, D. Santini, V. Catalano, R. Bisonni, U. Torresi, I. Floriani, G. Schiavon, et al. Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer J. Clin. Oncol., March 20, 2008; 26(9): 1427 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Y. Lui, A. L. Boehm, P. Koppikar, R. J. Leeman, D. Johnson, M. Ogagan, E. Childs, M. Freilino, and J. R. Grandis Antiproliferative Mechanisms of a Transcription Factor Decoy Targeting Signal Transducer and Activator of Transcription (STAT) 3: The Role of STAT1 Mol. Pharmacol., May 1, 2007; 71(5): 1435 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Harvey, N. Li, and D. P. Ramji Critical Role for Casein Kinase 2 and Phosphoinositide-3-Kinase in the Interferon-{gamma}-Induced Expression of Monocyte Chemoattractant Protein-1 and Other Key Genes Implicated in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kar, M. Wang, W. Yao, C. J. Michejda, and B. I. Carr PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol. Cancer Ther., June 1, 2006; 5(6): 1511 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Steiner, K. Holzmann, C. Pirker, L. Elbling, M. Micksche, H. Sutterluty, and W. Berger The major vault protein is responsive to and interferes with interferon-{gamma}-mediated STAT1 signals J. Cell Sci., February 1, 2006; 119(3): 459 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kar, M. Wang, K. S. Rosi, C. S. Wilcox, and B. I. Carr Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound Carcinogenesis, December 1, 2004; 25(12): 2345 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Andl, T. Mizushima, K. Oyama, M. Bowser, H. Nakagawa, and A. K. Rustgi EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1227 - G1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Baran-Marszak, J. Feuillard, I. Najjar, C. Le Clorennec, J.-M. Bechet, I. Dusanter-Fourt, G. W. Bornkamm, M. Raphael, and R. Fagard Differential roles of STAT1{alpha} and STAT1{beta} in fludarabine-induced cell cycle arrest and apoptosis in human B cells Blood, October 15, 2004; 104(8): 2475 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Frame Newest findings on the oldest oncogene; how activated src does it J. Cell Sci., March 1, 2004; 117(7): 989 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Klampfer, J. Huang, G. Corner, J. Mariadason, D. Arango, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ki-Ras Inhibits the Expression of Interferon-responsive Genes through Inhibition of STAT1 and STAT2 Expression J. Biol. Chem., November 21, 2003; 278(47): 46278 - 46287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dimberg, I. Karlberg, K. Nilsson, and F. Oberg Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells Blood, July 1, 2003; 102(1): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Mizel, A. N. Honko, M. A. Moors, P. S. Smith, and A. P. West Induction of Macrophage Nitric Oxide Production by Gram-Negative Flagellin Involves Signaling Via Heteromeric Toll-Like Receptor 5/Toll-Like Receptor 4 Complexes J. Immunol., June 15, 2003; 170(12): 6217 - 6223. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Richardson, C. Fielding, M. Rowe, and P. Brennan Epstein-Barr Virus Regulates STAT1 through Latent Membrane Protein 1 J. Virol., April 1, 2003; 77(7): 4439 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Habib, S. J. Chun, B. G. Neel, and T. Vartanian Increased Expression of Epidermal Growth Factor Receptor Induces Sequestration of Extracellular Signal-Related Kinases and Selective Attenuation of Specific Epidermal Growth Factor-Mediated Signal Transduction Pathways Mol. Cancer Res., January 1, 2003; 1(3): 219 - 233. [Abstract] [Full Text] |
||||
![]() |
A. Krause, N. Scaletta, J.-D. Ji, and L. B. Ivashkiv Rheumatoid Arthritis Synoviocyte Survival Is Dependent on Stat3 J. Immunol., December 1, 2002; 169(11): 6610 - 6616. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Wu, Y. K. Hong, X.-D. Wang, M. Y. Ling, A. M. Dragoi, A. S. Chung, A. G. Campbell, Z.-Y. Han, G.-S. Feng, and Y. E. Chin SHP-2 Is a Dual-specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in Nuclei J. Biol. Chem., November 27, 2002; 277(49): 47572 - 47580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fairley, J. Baillie, M. Bain, and J. H. Sinclair Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors J. Gen. Virol., November 1, 2002; 83(11): 2803 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu and J. A. Kern Neuregulin-1 Activates the JAK-STAT Pathway and Regulates Lung Epithelial Cell Proliferation Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 306 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Wong, H. Sim, M. Chatterjee-Kishore, I. Hatzinisiriou, R. J. Devenish, G. Stark, and S. J. Ralph Isolation and Characterization of a Human STAT1 Gene Regulatory Element. INDUCIBILITY BY INTERFERON (IFN) TYPES I AND II AND ROLE OF IFN REGULATORY FACTOR-1 J. Biol. Chem., May 24, 2002; 277(22): 19408 - 19417. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen, G. Devgan, J. E. Darnell Jr., and J. F. Bromberg Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1 PNAS, February 1, 2001; (2001) 41588198. [Abstract] [Full Text] |
||||
![]() |
A. Dimberg, K. Nilsson, and F. Oberg Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts Blood, October 15, 2000; 96(8): 2870 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gooch, R. E. Herrera, and D. Yee The Role of p21 in Interferon {{gamma}}-mediated Growth Inhibition of Human Breast Cancer Cells Cell Growth Differ., June 1, 2000; 11(6): 335 - 342. [Abstract] [Full Text] |
||||
![]() |
Y. Shirakata, T. Komurasaki, H. Toyoda, Y. Hanakawa, K. Yamasaki, S. Tokumaru, K. Sayama, and K. Hashimoto Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes J. Biol. Chem., February 25, 2000; 275(8): 5748 - 5753. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shi, H. Fan, L. Shum, and R. Derynck The Tetraspanin CD9 Associates with Transmembrane TGF-{alpha} and Regulates TGF-{alpha}-induced EGF Receptor Activation and Cell Proliferation J. Cell Biol., February 7, 2000; 148(3): 591 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishikawa, Z. Wang, J. Kerns, C. S. Wilcox, and B. I. Carr Inhibition of Hepatoma Cell Growth in Vitro by Arylating and Non-arylating K Vitamin Analogs. SIGNIFICANCE OF PROTEIN TYROSINE PHOSPHATASE INHIBITION J. Biol. Chem., December 3, 1999; 274(49): 34803 - 34810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Park, S. Carter, D. B. Reardon, R. Schmidt-Ullrich, P. Dent, and P. B. Fisher Roles for Basal and Stimulated p21Cip-1/WAF1/MDA6 Expression and Mitogen-activated Protein Kinase Signaling in Radiation-induced Cell Cycle Checkpoint Control in Carcinoma Cells Mol. Biol. Cell, December 1, 1999; 10(12): 4231 - 4246. [Abstract] [Full Text] |
||||
![]() |
P. Dent, D. B. Reardon, J. S. Park, G. Bowers, C. Logsdon, K. Valerie, and R. Schmidt-Ullrich Radiation-induced Release of Transforming Growth Factor alpha Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell Death Mol. Biol. Cell, August 1, 1999; 10(8): 2493 - 2506. [Abstract] [Full Text] |
||||
![]() |
J.F. BROMBERG and J.E. DARNELL Jr. Potential Roles of Stat1 and Stat3 in Cellular Transformation Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 425 - 428. [Abstract] [PDF] |
||||
![]() |
Y. Shen, G. Devgan, J. E. Darnell Jr., and J. F. Bromberg Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1 PNAS, February 13, 2001; 98(4): 1543 - 1548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |